8.96 USD
+0.05
0.56%
At close Updated May 15, 4:00 PM EDT
Pre-market
After hours
8.96
0.00
0%
1 day
0.56%
5 days
-1.86%
1 month
-7.25%
3 months
-20.21%
6 months
-7.44%
Year to date
-10.4%
1 year
-16.03%
5 years
19.47%
10 years
19.47%
 

About: Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Employees: 24,524

0
Funds holding %
of 7,907 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™